Key Pharmacy and Compounding Center recalls ATROPINE SULFATE 0.5% OPHTH, Ophthalmic 0.50%, Rx only, 15mlLGlass /Multiple Dose vial, Prepared by Key Compounding Phar
Recalled May 24, 2017 · FDA recall D-0712-2017 · Key Pharmacy and Compounding Center
Hazard
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility. · FDA Class II
Units
9 mL
Sold at
Distributed nationwide in U.S.A., Australia and Canada.
Description
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Product
ATROPINE SULFATE 0.5% OPHTH, Ophthalmic 0.50%, Rx only, 15mlLGlass /Multiple Dose vial, Prepared by Key Compounding Pharmacy
Manufacturer(s)
Key Pharmacy and Compounding Center
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →